Make Medicines Affordable
  • Home
  • About
  • Where we work
  • News
  • Strategies
  • Resources
  • Resources
    • Best practices and models
    • Community publications
    • Compulsory licencsing
    • COVID-19
    • GSIPA2M 2018
    • Hepatitis C
    • HIV
    • Patent law
    • Patent Opposition
    • Patents: the facts
    • Report
    • Research
    • Resource
    • Roadmap
    • TB
    • Trade agreements
    • TRIPS Agreement
    • Video

Indonesia Presidential Decree 101 – original

Compulsory licencsingCOVID-19Patent law

Indonesian

Download (pdf 341.22 KB)

Keep in Touch

Our email newsletter has latest news on developments and campaign actions

Twitter

  • RT @ITPCglobal: Join ITPC at #AIDS2022 on Mon 1 Aug for the plenary in Rm 220 (main plenary hall) at 4pm (Montreal time). In the session, I…

    10 days ago

Make Medicines Affordable Twitter

Instagram

Make Medicines Affordable campaign challenges abus Make Medicines Affordable campaign challenges abuses of the #patent system. Our strategies include making successful legal and technical interventions, in-line with international trade agreements, and working to strengthen patent laws to create long-term change. #MedicineEqualityNow © Bangkok, Thailand, 2019. © @gemmataylorphoto / Make Medicines Affordable
"We need spread more information around HIV and en "We need spread more information around HIV and ensure access to affordable treatment". Theo Keborate. #Botswana, 2021 © Letso Leipego/Majority World/Make Medicines Affordable/2021
#EyesOnPharmaGreed. We have it, do you? #Medicin #EyesOnPharmaGreed. We have it, do you? #MedicineEqualityNow and #AbolishTRIPS are the only way out of the COVID-19 pandemics and others to come. Everyone everywhere has the right to survive. Everyone everywhere has the right to affordable treatments. @worldtradeorganization could end the pandemics now. Everyday it passes, the world looses more lives to a disease that already has a vaccine.
Who decides if you get a life-saving vaccine? Th Who decides if you get a life-saving vaccine? The world's essential medicines are controlled by a wealthy few, but it's time to take them back. Watch our animation to discover more. #MedicineEqualityNow #FightToSurvive #AbolishTRIPS

Make Medicines Affordable Instagram

Facebook

ITPC Executive Director Solange Baptiste delivered a plenary address on health innovation, entitled “Community Data Matters: A Look Into Community-led Monitoring" at #AIDS2022 on Monday 1st of August in Montreal. The presentation touched upon what CLM is (and what it is not), the steps in the CLM methodology, and concrete examples of how CLM-derived data has been used to engage with decision-makers to achieve concrete changes for people living with HIV, including: - expansion of multi-month dispensation of ART, - reduction in stock-out times, - and faster return of viral load results. CLM data has also been used to identify weaknesses in health systems, including: - documentation of stigmatizing healthcare provider behavior against key populations;- massive drops in HIV testing rates in the COVID era (especially among KPs); - and spikes in teenage pregnancies exactly 9 months after COVID lockdowns.She closed by making the point that although some progress has been made "We are still skeptical about the community role beyond advocacy and demand creation leading to under valuing of community data and by extension CLM." She put a challenge to the HIV response in line with the famous proverb quoted by Chinua Achebe, “Until the lions have their own historians, the history of the hunt will always glorify the hunter."For more info, visit our new home of community-led monitoring, the CLMhub.org #itpcataids2022 #watchwhatmatters #HIV #treatpeopleright #montreal #reengage #followthescience #CLM #communityledmonitoring ... See MoreSee Less

1 week ago  ·  

ITPC global Facebook

© Copyright ITPC 2022 Cookies Media enquiries Contact us Website by Maraid Design

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}